THE POLYMORBIDITY AND THE EFFICIENCY OF STABLE CHD BETA-BLOCKERS TREATMENT IN THE POST-INFARCTION PERIOD

С. Бунова, Н. А. Николаев, Е. В. Усачева, А. В. Нелидова, Л. А. Живилова, O. V. Zamakhina, S. Bunova, N. A. Nikolayev, E. Usacheva, A. V. Nelidova, L. Zhivilova
{"title":"THE POLYMORBIDITY AND THE EFFICIENCY OF STABLE CHD BETA-BLOCKERS TREATMENT IN THE POST-INFARCTION PERIOD","authors":"С. Бунова, Н. А. Николаев, Е. В. Усачева, А. В. Нелидова, Л. А. Живилова, O. V. Zamakhina, S. Bunova, N. A. Nikolayev, E. Usacheva, A. V. Nelidova, L. Zhivilova","doi":"10.18413/2075-4728-2019-42-2-180-193","DOIUrl":null,"url":null,"abstract":"The effect of co-and polymorbidity in increasing the heart rate (HR) pathology on achieving the target HR in the beta-adrenergic blockers (BAB) treatment of patients with stable coronary heart disease (CHD) after myo­ cardial infarction (MI) is studied. As part of an open, one-center, comparative study, 320 patients who had had MI more than 6 months ago were examined. They were counted on an outpatient HR and selected the optimal maximum tolerated dose of BAB in achieving HR, then were divided into 2 groups: 1) with a resting HR <60 per min. and 2) with resting HR> 60 per min. Co-and polymorbidity in increasing the HR pathology and its severity in the studied groups were identified and compared. Results: co-and polymorbidity in the increasing НАУЧНЫЕ ВЕДОМОСТИ Серия: Медицина. Фармация. 2019. Том 42, No 2 181 the HR pathology was significantly more common in patients with heart rate> 60 per 1 min .: smoking (p = 0.002); latent alcohol abuse (p = 0.024); carbohydrate metabolism disorders (p = 0.01); congestive heart failure (p = 0.01) with a functional class of 3 or more (p = 0.02); anemia (p = 0.04) and latent iron deficiency (p = 0.02); respiratory failure of 2 or more degrees (p = 0.03); high situational (p = 0.01) and high personal anxiety (p = 0.007). The number of co-and polymorbidity in the increasing HR pathologies in the group with HR> 60 in 1 min. were more: more patients with three (p = 0.008), four or more (p <0.001) of such diseases and condi­ tions at the same time. The Charlson comorbidity index was also higher in this group (p <0.05). Conclusion: in 55.9% of the studied patients it was not possible to reach the target HR, it was associated with an older age (p = 0.048) and the presence of co-and polymorbidity in the increasing HR pathology. Ключевые слова: стабильная ишемическая болезнь сердца, инфаркт миокарда, коморбидная патология, полиморбидная патология, целевая частота сердечных сокращений.","PeriodicalId":8785,"journal":{"name":"Belgorod State University Scientific bulletin Medicine Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Belgorod State University Scientific bulletin Medicine Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18413/2075-4728-2019-42-2-180-193","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The effect of co-and polymorbidity in increasing the heart rate (HR) pathology on achieving the target HR in the beta-adrenergic blockers (BAB) treatment of patients with stable coronary heart disease (CHD) after myo­ cardial infarction (MI) is studied. As part of an open, one-center, comparative study, 320 patients who had had MI more than 6 months ago were examined. They were counted on an outpatient HR and selected the optimal maximum tolerated dose of BAB in achieving HR, then were divided into 2 groups: 1) with a resting HR <60 per min. and 2) with resting HR> 60 per min. Co-and polymorbidity in increasing the HR pathology and its severity in the studied groups were identified and compared. Results: co-and polymorbidity in the increasing НАУЧНЫЕ ВЕДОМОСТИ Серия: Медицина. Фармация. 2019. Том 42, No 2 181 the HR pathology was significantly more common in patients with heart rate> 60 per 1 min .: smoking (p = 0.002); latent alcohol abuse (p = 0.024); carbohydrate metabolism disorders (p = 0.01); congestive heart failure (p = 0.01) with a functional class of 3 or more (p = 0.02); anemia (p = 0.04) and latent iron deficiency (p = 0.02); respiratory failure of 2 or more degrees (p = 0.03); high situational (p = 0.01) and high personal anxiety (p = 0.007). The number of co-and polymorbidity in the increasing HR pathologies in the group with HR> 60 in 1 min. were more: more patients with three (p = 0.008), four or more (p <0.001) of such diseases and condi­ tions at the same time. The Charlson comorbidity index was also higher in this group (p <0.05). Conclusion: in 55.9% of the studied patients it was not possible to reach the target HR, it was associated with an older age (p = 0.048) and the presence of co-and polymorbidity in the increasing HR pathology. Ключевые слова: стабильная ишемическая болезнь сердца, инфаркт миокарда, коморбидная патология, полиморбидная патология, целевая частота сердечных сокращений.
冠心病β受体阻滞剂在梗死后稳定治疗的多发病及疗效
研究了心肌梗死(MI)后稳定型冠心病(CHD)患者应用β -肾上腺素能阻滞剂(BAB)治疗时心率(HR)病理升高的共发病和多发病对达到目标HR的影响。作为一项开放的、单中心的比较研究的一部分,对320名6个月以上的心肌梗死患者进行了检查。对患者进行门诊HR统计,并选择达到HR的最佳最大耐受剂量,然后分为两组:1)静息HR为每分钟60。确定并比较两组患者HR病理加重及其严重程度的共发病和多发病情况。结果:co和polymorbidity在增加НАУЧНЫЕВЕДОМОСТИСерия:Медицина。Фармация。2019. Том 42, No . 2 181 HR病理在心率> 60 / 1 min的患者中更为常见:吸烟(p = 0.002);潜伏性酒精滥用(p = 0.024);碳水化合物代谢紊乱(p = 0.01);充血性心力衰竭(p = 0.01),功能等级为3级或以上(p = 0.02);贫血(p = 0.04)和潜伏性缺铁(p = 0.02);呼吸衰竭2度及以上(p = 0.03);高情境焦虑(p = 0.01)和高个人焦虑(p = 0.007)。1 min内HR> 60组合并合并多发病较多:同时合并3种(p = 0.008)、4种及以上(p <0.001)的患者较多。对照组的Charlson合并症指数也高于对照组(p <0.05)。结论:55.9%的患者无法达到目标HR,与年龄增大有关(p = 0.048), HR病理增加存在共发病和多发病。Ключевыеслова:стабильнаяишемическаяболезньсердца,инфарктмиокарда,коморбиднаяпатология,полиморбиднаяпатология,целеваячастотасердечныхсокращений。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信